HOME >> MEDICINE >> NEWS
Yale study shows 25 percent of obese children are at high risk for developing diabetes

e children during the four-year course of the study progressed from glucose intolerance to diabetes.

Fourteen of the girls had polycystic ovary syndrome, which causes symptoms such as menstrual irregularities, hirsutism due to high androgen levels, and, over time, infertility, as well as cysts on their ovaries. The syndrome also is associated with darkening and thickening of the skin around the neck and under the arms.

Possible long term complications from diabetes include premature artherosclerosis, often affecting the legs and leading to ulcers of the feet; early coronary artery disease; kidney disorders; eye disorders, sometimes leading to blindness, and nerve problems.


'"/>

Contact: Jacqueline Weaver
jacqueline.weaver@yale.edu
203-432-8555
Yale University
13-Mar-2002


Page: 1 2

Related medicine news :

1. First head-to-head study to compare lidoderm patch and Celebrex in treating pain
2. UMaine study looks at infants and chronic nighttime crying
3. Chronic pain treatments more effective when taken together, new study shows
4. UNC study: Most N.C. family practitioners engage in unrecognized community service
5. New study in Nature demonstrates protection against cell death during heart attack
6. UCSF study offers insight into human circadian rhythms
7. International breast cancer prevention study launches in the United States and Canada
8. UW study shows blacks and Latinos are more satisfied with physicians of the same race
9. Physicians may not be accurate in their confidence levels of their diagnoses, says Pitt study
10. Advertising by academic medical centers may risk eroding public trust, says study
11. Fat may promote inflammation, new study suggests

Post Your Comments:
(Date:4/1/2015)... 2015 San Francisco based sustainable medical ... medical charity, Operation Smile, have launched a ... Campaign Details: RxOrganics is generously donating 5% of ... Operation Smile throughout 2015. RxOrganics has committed to an ... that every order placed online through the Rxmedical shop ...
(Date:4/1/2015)... April 01, 2015 Results are in ... , which featured 11 new homes from across the ... that best utilized innovative building techniques and new technology ... Steven Winter Associates, Inc. (SWA) provided sustainability consulting services ... year’s challenge, including the first- and third-place winners. , ...
(Date:4/1/2015)... 01, 2015 Poisonous plants (poison ivy, ... change in recent years, increasing significantly in number and ... if exposed to poison plants (according to the American ... prepare for summer adventures in nature, they should be ... reaction is greater than ever. This year, Ivarest adds ...
(Date:3/31/2015)... Bon Secours New York Health System ... Nursing Care Center family last week. The Sisters formerly ... Yonkers which is scheduled to close later this year. ... the Sisters of Charity of New York, the decision ... place their Sisters at Schervier Nursing Care Center followed ...
(Date:3/31/2015)... As the demand for optimized mobile content ... a mobile-friendly website online sometime during the month of ... continued commitment to bring the best and most accurate ... the same great fitness information at http://www.chunkfitness.com ... to read while browsing on a mobile device. , ...
Breaking Medicine News(10 mins):Health News:RxOrganics Forges Unique Partnership to Bring More Smiles to Underserved Global Heath Communities 2Health News:Steven Winter Associates’ Projects Receive Top Honors in CT Zero Energy Challenge 2Health News:Steven Winter Associates’ Projects Receive Top Honors in CT Zero Energy Challenge 3Health News:Steven Winter Associates’ Projects Receive Top Honors in CT Zero Energy Challenge 4Health News:New Ivarest Poison Ivy Itch Spray Provides All-Day Comfort 2Health News:Bon Secours New York Health System Welcomes Retired Sisters of Charity to the Family 2
(Date:3/31/2015)... 2015 Neurocrine Biosciences, Inc. (Nasdaq: NBIX ... exclusive collaboration and licensing agreement for the development and ... Japan and other select Asian markets with ... to initially develop NBI-98854 in Japan ... tardive dyskinesia. Neurocrine retains full commercial rights to NBI-98854 ...
(Date:3/31/2015)... UHC has released the findings of a ... based on cost and quality outcomes to uncover several ... study examined utilization of PPIs—which can account for 30% ... 10 academic medical centers, focusing on procedures utilizing orthopedic ... The study, begun in 2013, integrated the ...
(Date:3/31/2015)... N.Y., March 31, 2015 Uroplasty, Inc. (NASDAQ: ... the completion of their merger. The merger was ... the all-stock combination creates a new medical device ... 1, 2015, Cogentix Medical, Inc. will trade on ... will have its U.S. headquarters in ...
Breaking Medicine Technology:Neurocrine Biosciences and Mitsubishi Tanabe Pharma Announce Agreement to Develop and Commercialize VMAT2 Inhibitor NBI-98854 for Movement Disorders in Japan and Other Select Asian Markets 2Neurocrine Biosciences and Mitsubishi Tanabe Pharma Announce Agreement to Develop and Commercialize VMAT2 Inhibitor NBI-98854 for Movement Disorders in Japan and Other Select Asian Markets 3Neurocrine Biosciences and Mitsubishi Tanabe Pharma Announce Agreement to Develop and Commercialize VMAT2 Inhibitor NBI-98854 for Movement Disorders in Japan and Other Select Asian Markets 4UHC Study: Variations in Use of Physician Preference Items Affect Patient Outcomes and Costs 2UHC Study: Variations in Use of Physician Preference Items Affect Patient Outcomes and Costs 3Uroplasty and Vision-Sciences Complete Merger 2Uroplasty and Vision-Sciences Complete Merger 3Uroplasty and Vision-Sciences Complete Merger 4
Cached News: